We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$135M
AUM Growth
+$5.13M
Cap. Flow
+$2.88M
Cap. Flow %
2.13%
Top 10 Hldgs %
22.44%
Holding
185
New
26
Increased
50
Reduced
55
Closed
31

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$1.2M
2
COST icon
Costco
COST
+$1.15M
3
AMGN icon
Amgen
AMGN
+$1.07M
4
DY icon
Dycom Industries
DY
+$931K
5
LOW icon
Lowe's Companies
LOW
+$899K

Sector Composition

Rank Sector Weight
1 Industrials 21.57%
2 Healthcare 18.97%
3 Financials 18.11%
4 Consumer Staples 13.07%
5 Technology 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
101
GSK
GSK
$103B
$434K 0.32%
8,045
-360
-4% -$19.2K
CTRA
102
DELISTED
Coterra Energy
CTRA
$426K 0.32%
+17,000
New +$401K
HD icon
103
Home Depot
HD
$348B
$424K 0.31%
2,766
-75
-3% -$11.5K
C icon
104
Citigroup
C
$230B
$413K 0.31%
6,177
-800
-11% -$49.1K
A icon
105
Agilent Technologies
A
$39.3B
$397K 0.29%
6,700
+1,350
+25% +$76.9K
GWW icon
106
W.W. Grainger
GWW
$61.4B
$396K 0.29%
+2,195
New +$414K
WPC icon
107
W.P. Carey
WPC
$16.5B
$380K 0.28%
5,880
AAL icon
108
American Airlines Group
AAL
$11B
$367K 0.27%
7,300
-16,950
-70% -$788K
CME icon
109
CME Group
CME
$94.6B
$363K 0.27%
2,895
-200
-6% -$23.9K
SBUX icon
110
Starbucks
SBUX
$120B
$362K 0.27%
6,200
-1,500
-19% -$90.7K
HQY icon
111
HealthEquity
HQY
$8.8B
$357K 0.26%
7,160
-2,840
-28% -$133K
LLY icon
112
Eli Lilly
LLY
$992B
$354K 0.26%
+4,300
New +$351K
NOC icon
113
Northrop Grumman
NOC
$78.5B
$353K 0.26%
1,375
DAL icon
114
Delta Air Lines
DAL
$61.2B
$352K 0.26%
6,550
-700
-10% -$34.3K
GEN icon
115
Gen Digital
GEN
$17B
$345K 0.26%
+12,200
New +$369K
BNS icon
116
Scotiabank
BNS
$106B
$343K 0.25%
5,700
+75
+1% +$4.3K
SQM icon
117
Sociedad Química y Minera de Chile
SQM
$19.6B
$343K 0.25%
+10,400
New +$365K
BNY
118
Bank of New York Mellon
BNY
$107B
$337K 0.25%
+6,600
New +$316K
FAST icon
119
Fastenal
FAST
$56.9B
$337K 0.25%
+31,000
New +$348K
ABBV icon
120
AbbVie
ABBV
$431B
$334K 0.25%
4,608
WMT icon
121
Walmart Inc
WMT
$888B
$332K 0.25%
13,161
ROL icon
122
Rollins
ROL
$18.2B
$313K 0.23%
17,325
FLG
123
Flagstar Bank National Association
FLG
$5.94B
$310K 0.23%
7,867
+117
+2% +$4.65K
VTRS icon
124
Viatris
VTRS
$20.6B
$307K 0.23%
7,900
-550
-7% -$21.1K
WOOF
125
DELISTED
VCA Inc.
WOOF
$295K 0.22%
3,200

Similar funds

New England Research & Management's Q2 2017 Portfolio in Review

As of Q2 2017, New England Research & Management held 185 positions worth $135M, up 3.9% from $130M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q2 2017 filing shows 26 new, 50 increased, 55 reduced and 31 closed positions. Its largest new stake was Norfolk Southern: 10,247 shares worth $1.25M. The largest sale was Toll Brothers, an estimated $1.28M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q2 2017 buy was Norfolk Southern: 10,247 shares worth $1.25M.
  • New England Research & Management added most to Costco in Q2 2017, an estimated $1.15M increase.
  • New England Research & Management's biggest Q2 2017 reduction was CVS Health, cutting an estimated $910K.
  • New England Research & Management fully exited Toll Brothers in Q2 2017, selling an estimated $1.28M.
  • New England Research & Management's ten largest holdings make up 22% of its $135M portfolio in Q2 2017.
  • New England Research & Management opened 26 new positions and closed 31 in Q2 2017.
  • New England Research & Management's portfolio value rose 3.9% quarter-over-quarter to $135M.

Based on New England Research & Management's 13F filing for Q2 2017, filed 11 Jul 2017.